FDA Approves First 3D Printed Drug

3-d_printing_drugThe U.S. Food and Drug Administration (FDA) approved the first 3D-printed drug this month, Spritam, designed to treat seizures brought on by epilepsy in children and adults. It was developed by Aprecia Pharmaceuticals Company using ZipDose, a 3D printer that creates pills by printing out thin layers of powder, with layers of a water-based binder spread in between. Tablets made with ZipDose technology can dissolve with a sip of water in less than five seconds. The plan is for Spritam to be commercially available in early 2016.

Zintro expert Scott Bork is President of Medical Inspirations, LLC. He commented on the future of 3D printing, calling it an “exciting and welcome innovation to the world of pharmaceutical development.”

“The evolvement of technology into healthcare is rapidly changing every component of medicine,” said Bork. “It is not surprising that 3D printing has entered the healthcare market already, rapidly advancing prototypes for medical devices that would take months to complete in the past.

“Using 3D printing and the development of a water-based medium with layered medicine will change the future of drug manufacturing. This unique process will also allow the entry of much smaller firms into the development and manufacturing process, lowering the staggering costs of the development of drugs.”

Zintro has experts in every industry sector, across every job function, in every geographic region. Recently, some of the following topics have seen inquiry activity: